Fundraising FoxMinoryx Therapeutics
Mataró, ES · 15 known investors
Find your way into Minoryx Therapeutics
Sign up to see every warm intro you have to Minoryx Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Minoryx Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Minoryx is a registration-stage biotech company developing novel therapies for severe, orphan genetic diseases of the central nervous system, with a lead compound (leriglitazone) in clinical trials for conditions including cerebral adrenoleukodystrophy, Friedreich's Ataxia, and Rett syndrome.
Founders & leadership
Investors · 15
How we know: Chiesi Ventures's portfolio page · globalgenes.org · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Criteria Bio Ventures's portfolio page · Not right? Tell us
How we know: Fund+'s portfolio page · globalgenes.org · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Kurma Partners's portfolio page · a partner's Signal profile · globalgenes.org · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Roche Venture Fund's portfolio page · a partner's Signal profile · globalgenes.org · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Ysios Capital's portfolio page · a partner's Signal profile · funding news · globalgenes.org · the VCSheet dataset · Not right? Tell us
How we know: funding news · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
How we know: globalgenes.org · Not right? Tell us
How we know: globalgenes.org · Not right? Tell us
How we know: globalgenes.org · Not right? Tell us
Also in the syndicate · 3
Funding
SEC filings, press & company announcements- Undisclosed amountseries BSep 2018
Fund+ (lead), Caixa Capital Risc, Chiesi Ventures, HealthEquity, Idinvest Partners, Kurma Partners, Roche Venture Fund, S.R.I.W., Sambrinvest, SFPI-FPIM, Ysios Capital
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Minoryx Therapeutics do?
- Minoryx is a registration-stage biotech company developing novel therapies for severe, orphan genetic diseases of the central nervous system, with a lead compound (leriglitazone) in clinical trials for conditions including cerebral adrenoleukodystrophy, Friedreich's Ataxia, and Rett syndrome.
- Who founded Minoryx Therapeutics?
- Minoryx Therapeutics was founded by Marc Martinell.
- Who are Minoryx Therapeutics's investors?
- Minoryx Therapeutics's investors include Chiesi Ventures, Criteria Bio Ventures, Fund+, Invivo Capital Partners, Kurma Partners, Roche Venture Fund, Ysios Capital, Columbus Venture Partners and 4 more.
- Where is Minoryx Therapeutics headquartered?
- Minoryx Therapeutics is headquartered in Mataró, ES.